ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Numab Therapeutics secures $110m in Series C funding round pharmaceutical-technology
May 24, 2021Numab Therapeutics has raised approximately $110m (CHF100m) through Series C funding to expedite the clinical development of its multi-specific antibody pipeline in oncology and inflammation. -
Numab closes $23.6m Series B round led by Asian investors pharmaceutical-technology
March 11, 2020Swiss biotech Numab has raised CHF22m ($22.7m) in a Series B financing round, which attracted multiple new investors from Asia, including 3SBio, Mitsubishi UFJ Capital and Eisai, as well as a company board member Dr Daniel Vasella.
Pharma Sources Insight January 2025
